188 related articles for article (PubMed ID: 38332150)
1. Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12.
Li L; Zeng J; Zhang X; Feng Y; Lei JH; Xu X; Chen Q; Deng CX
EMBO Rep; 2024 Mar; 25(3):1361-1386. PubMed ID: 38332150
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic SIRT6-mediated ACSL5 deacetylation impedes nonalcoholic fatty liver disease by facilitating hepatic fatty acid oxidation.
Hou T; Tian Y; Cao Z; Zhang J; Feng T; Tao W; Sun H; Wen H; Lu X; Zhu Q; Li M; Lu X; Liu B; Zhao Y; Yang Y; Zhu WG
Mol Cell; 2022 Nov; 82(21):4099-4115.e9. PubMed ID: 36208627
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte Sirtuin 6 Protects against Atherosclerosis and Steatohepatitis by Regulating Lipid Homeostasis.
Zhu Y; Hu S; Pan X; Gopoju R; Cassim Bawa FN; Yin L; Xu Y; Zhang Y
Cells; 2023 Aug; 12(15):. PubMed ID: 37566087
[TBL] [Abstract][Full Text] [Related]
4. Human centenarian-associated SIRT6 mutants modulate hepatocyte metabolism and collagen deposition in multilineage hepatic 3D spheroids.
Frohlich J; Raffaele M; Skalova H; Leire E; Pata I; Pata P; Gorbunova V; Vinciguerra M
Geroscience; 2023 Apr; 45(2):1177-1196. PubMed ID: 36534275
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin-Specific Peptidase 10 (USP10) Inhibits Hepatic Steatosis, Insulin Resistance, and Inflammation Through Sirt6.
Luo P; Qin C; Zhu L; Fang C; Zhang Y; Zhang H; Pei F; Tian S; Zhu XY; Gong J; Mao Q; Xiao C; Su Y; Zheng H; Xu T; Lu J; Zhang J
Hepatology; 2018 Nov; 68(5):1786-1803. PubMed ID: 29698567
[TBL] [Abstract][Full Text] [Related]
6. Deacetylation of XBP1s by sirtuin 6 confers resistance to ER stress-induced hepatic steatosis.
Bang IH; Kwon OK; Hao L; Park D; Chung MJ; Oh BC; Lee S; Bae EJ; Park BH
Exp Mol Med; 2019 Sep; 51(9):1-11. PubMed ID: 31541078
[TBL] [Abstract][Full Text] [Related]
7. Sirtuin 6-A Key Regulator of Hepatic Lipid Metabolism and Liver Health.
Dong XC
Cells; 2023 Feb; 12(4):. PubMed ID: 36831330
[TBL] [Abstract][Full Text] [Related]
8. SIRT6 controls hepatic lipogenesis by suppressing LXR, ChREBP, and SREBP1.
Zhu C; Huang M; Kim HG; Chowdhury K; Gao J; Liu S; Wan J; Wei L; Dong XC
Biochim Biophys Acta Mol Basis Dis; 2021 Dec; 1867(12):166249. PubMed ID: 34425214
[TBL] [Abstract][Full Text] [Related]
9. Diosgenin attenuates non-alcoholic fatty liver disease in type 2 diabetes through regulating SIRT6-related fatty acid uptake.
Nie K; Gao Y; Chen S; Wang Z; Wang H; Tang Y; Su H; Lu F; Dong H; Fang K
Phytomedicine; 2023 Mar; 111():154661. PubMed ID: 36682299
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte-specific sirtuin 6 deletion predisposes to nonalcoholic steatohepatitis by up-regulation of Bach1, an Nrf2 repressor.
Ka SO; Bang IH; Bae EJ; Park BH
FASEB J; 2017 Sep; 31(9):3999-4010. PubMed ID: 28536120
[TBL] [Abstract][Full Text] [Related]
11. CD38 Deficiency Protects Mice from High Fat Diet-Induced Nonalcoholic Fatty Liver Disease through Activating NAD
Xie L; Wen K; Li Q; Huang CC; Zhao JL; Zhao QH; Xiao YF; Guan XH; Qian YS; Gan L; Wang LF; Deng KY; Xin HB
Int J Biol Sci; 2021; 17(15):4305-4315. PubMed ID: 34803499
[TBL] [Abstract][Full Text] [Related]
12. SIRT6 Protects Against Liver Fibrosis by Deacetylation and Suppression of SMAD3 in Hepatic Stellate Cells.
Zhong X; Huang M; Kim HG; Zhang Y; Chowdhury K; Cai W; Saxena R; Schwabe RF; Liangpunsakul S; Dong XC
Cell Mol Gastroenterol Hepatol; 2020; 10(2):341-364. PubMed ID: 32305562
[TBL] [Abstract][Full Text] [Related]
13. The epigenetic regulator SIRT6 protects the liver from alcohol-induced tissue injury by reducing oxidative stress in mice.
Kim HG; Huang M; Xin Y; Zhang Y; Zhang X; Wang G; Liu S; Wan J; Ahmadi AR; Sun Z; Liangpunsakul S; Xiong X; Dong XC
J Hepatol; 2019 Nov; 71(5):960-969. PubMed ID: 31295533
[TBL] [Abstract][Full Text] [Related]
14. GB1a Activates SIRT6 to Regulate Lipid Metabolism in Mouse Primary Hepatocytes.
Sun Y; Zheng C; Li T; He X; Yang F; Guo W; Song J; Gao Y; Deng C; Huang X
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298491
[TBL] [Abstract][Full Text] [Related]
15. Valdecoxib attenuates lipid-induced hepatic steatosis through autophagy-mediated suppression of endoplasmic reticulum stress.
Park SY; Cho W; Abd El-Aty AM; Hacimuftuoglu A; Jeong JH; Jung TW
Biochem Pharmacol; 2022 May; 199():115022. PubMed ID: 35358477
[TBL] [Abstract][Full Text] [Related]
16. Sirt6 deletion in hepatocytes increases insulin sensitivity of female mice by enhancing ERĪ± expression.
Tang C; Liu P; Zhou Y; Jiang B; Song Y; Sheng L
J Cell Physiol; 2019 Aug; 234(10):18615-18625. PubMed ID: 30912134
[TBL] [Abstract][Full Text] [Related]
17. SIRT6: therapeutic target for nonalcoholic fatty liver disease.
Zang M; Gao B
Trends Endocrinol Metab; 2022 Dec; 33(12):801-803. PubMed ID: 36328906
[TBL] [Abstract][Full Text] [Related]
18. A novel role of CRTC2 in promoting nonalcoholic fatty liver disease.
Han HS; Kim SG; Kim YS; Jang SH; Kwon Y; Choi D; Huh T; Moon E; Ahn E; Seong JK; Kweon HS; Hwang GS; Lee DH; Cho KW; Koo SH
Mol Metab; 2022 Jan; 55():101402. PubMed ID: 34838715
[TBL] [Abstract][Full Text] [Related]
19. FOXA3 induction under endoplasmic reticulum stress contributes to non-alcoholic fatty liver disease.
Liu C; Zhou B; Meng M; Zhao W; Wang D; Yuan Y; Zheng Y; Qiu J; Li Y; Li G; Xiong X; Bian H; Zhang H; Wang H; Ma X; Hu C; Xu L; Lu Y
J Hepatol; 2021 Jul; 75(1):150-162. PubMed ID: 33548387
[TBL] [Abstract][Full Text] [Related]
20. [The role of SIRT6 in nonalcoholic steatohepatitis].
Jing XD; Tang Q; He JH
Sheng Li Xue Bao; 2021 Oct; 73(5):745-754. PubMed ID: 34708231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]